Discover
News, reviews, and guides — searchable in one place.
Heads up: aggregated news headlines are not independently verified — read with care.
- TechnologyDiabetes Daily20633d ago
Next-gen CGM cuts calibration to once a week in pivotal trial
A multi-center study reports improved MARD and a 7-day wear window with no fingerstick calibration required in 92% of participants.
- ResearchJAMA20634d ago
Hybrid closed-loop systems reduce nocturnal hypos by 38%
Pooled analysis of three RCTs in adolescents and adults with T1D shows meaningful overnight time-in-range gains.
- Type 2Reuters Health20634d ago
Once-weekly basal insulin approved for type 2 diabetes
Regulators clear a long-acting analog dosed once weekly, opening the door to simpler titration regimens.
- TechnologyMobiHealthNews20635d ago
Smart insulin pens gain dose-recommendation features
Two major pen platforms add bolus calculators that read CGM data directly from the wearer's phone.
- Type 1Diabetes Care20636d ago
Teplizumab real-world data: average delay of T1D onset now 3.1 years
Registry follow-up extends the original Phase 2 findings in stage-2 at-risk individuals.
- PolicyWHO20636d ago
WHO updates global diabetes technology access targets
New benchmarks call for affordable CGM access in 60% of low- and middle-income countries by 2030.